Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
About Marketexclusive.com Contributors
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
About Marketexclusive.com Contributors
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Stocks
Stocks
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Constellation Brands, Inc. Class A (NYSE:STZ) reported earnings of $2.20 per share missing Walls Streets expectations.
ME Staff
-
June 29, 2018
SCANA (NYSE:SCG) announces a quarterly dividend of $0.1237
Shaw Communications Inc Class B (NYSE:SJR) reported earnings of ($0.18) per share missing Walls Streets expectations.
OMNOVA Solutions (NYSE:OMN) reported earnings of $0.20 per share beating Walls Streets expectations.
Lindsay (NYSE:LNN) reported earnings of $0.96 per share missing Walls Streets expectations.
Is the Axovant IPO a Biotech Red Flag?
ME Staff
-
July 7, 2015
0
Celgene Values Juno at Twice Market Rate; Valid Upside Target?
ME Staff
-
June 30, 2015
0
As Good News Flows Out, Smart Money Flows into Juno Therapeutics
ME Staff
-
June 26, 2015
0
Tekmira’s Ebola Drug Out Of the Race; Who’s Left in?
ME Staff
-
June 23, 2015
0
Another Win for RedHill – What’s Next?
ME Staff
-
June 16, 2015
0
Up-listing Could Prove Pivotal for Pieris
ME Staff
-
June 11, 2015
0
Celgene Realigns Bluebird Collaboration; Good or Bad?
ME Staff
-
June 5, 2015
0
Xanthopoulos Steps down, Trouble Brewing for Regulus?
ME Staff
-
June 3, 2015
0
Clovis up on Ovarian Cancer, Lung Cancer Reports
ME Staff
-
June 1, 2015
0
Cellectis Up On Pfizer Rumors; A Good Time to Buy?
ME Staff
-
May 29, 2015
0
1
...
727
728
729
Page 728 of 729
// AST – IMS - [MarketExclusive_ROS]
